Copyright
©The Author(s) 2020.
World J Gastrointest Oncol. Nov 15, 2020; 12(11): 1272-1287
Published online Nov 15, 2020. doi: 10.4251/wjgo.v12.i11.1272
Published online Nov 15, 2020. doi: 10.4251/wjgo.v12.i11.1272
Figure 4 miR-663a inhibits pancreatic cancer cell growth by targeting Sox12.
A: Dual-luciferase reporter assay confirmed the relationship between miR-663a and Sox12; B: Expression of Sox12 in patients with pancreatic cancer; C: Sox12 was negatively correlated with miR-663a and positively correlated with C9orf139; D: Relative expression of Sox12 mRNA and protein in cells after transfection; E: Inhibited cell proliferation in pancreatic cancer cells transfected with si-Sox12; F: Inhibited cell invasion in pancreatic cancer cells transfected with si-Sox12; G: Inhibited cell migration in pancreatic cancer cells transfected with si-Sox12; H: Increased cell apoptosis in pancreatic cancer cells transfected with si-Sox12. bP < 0.01 compared with the control group; eP < 0.001 compared with the control group.
- Citation: Ge JN, Yan D, Ge CL, Wei MJ. LncRNA C9orf139 can regulate the growth of pancreatic cancer by mediating the miR-663a/Sox12 axis. World J Gastrointest Oncol 2020; 12(11): 1272-1287
- URL: https://www.wjgnet.com/1948-5204/full/v12/i11/1272.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v12.i11.1272